search

The Commission has published its proposal for Horizon Europe, an ambitious €100 billion research and innovation programme that will succeed Horizon 2020.

The proposal was made as part of the EU’s proposal for the next EU long-term budget, the multiannual financial framework (MFF).

Various building blocks were taken into account including the interim evaluation of Horizon 2020, the Lab-Fab-App report (informally the Lamy report), foresight studies and various other reports.

Pursuing a mission-oriented policy approach

Horizon Europe will incorporate policy missions to ensure the effectiveness of research and innovation funding by pursuing clearly defined targets.

The Commission has engaged policy experts to develop studies, case studies and reports on how a mission-oriented policy approach will work.

Reports and materials that shaped the proposal

Evaluating Horizon 2020

To make an effective proposal, the Commission built on what has been learned from Horizon 2020.

Mission-oriented policy

Future scenarios

Foresight study to prepare scenarios for future contexts of EU research and innovation policy.

Economic rationale

Analysis to set out the economic rationale for public R&I investments and their impact on growth and jobs carried out by the Commission.

Involving citizens in setting priorities for the next framework programme

Report by the Democratic Society on involving citizens in the next framework programme

Report of the high level group on the European Innovation Council

Europe is back: Accelerating breakthrough innovation recommendations on how a European Innovation Council (EIC) should be set up to fund and nurture breakthrough innovation.

Adoption timeline

  • 2 May 2018 the Commission adopts its proposal for the next EU long-term budget (MFF)
  • 7 June 2018 the Commission adopts its proposal for Horizon Europe
  • the Council and European Parliament negotiate and subsequently adopt the programme
  • Horizon Europe is launched on 1 January 2021

Read more

Innovative Medicines Initiative: “A human adventure”

07-11-2018

One of Luxembourg’s main hospitals, the Centre Hospitalier de Luxembourg (CHL), is actively taking part in the European project INNODIA that aims to fight type 1 diabetes. The project receives funding from the Innovative Medicines Initiative (IMI), the world’s biggest public-private partnership in the field of life sciences.
Read more

Winter key events for Horizon 2020

07-11-2018

Luxinnovation’s EU Funding team has compiled all important info days, brokerage events, congresses and conferences until the end of 2018. Please take a look at the list and choose the events that are the most interesting for you. For any more questions, please do not hesitate to contact us.
Read more

Funding, network, innovation

31-10-2018

Two more years and ample budgets still remain of Horizon 2020, the EU’s framework programme for research and innovation for the period 2014-2020. Over 80 participants joined Luxinnovation’s Horizon 2020 Day on 25 October to discover the funding opportunities available in 2019 and 2020 and learn more about how to apply for funding and manage Horizon 2020 projects with success.
Read more

EU Battery Alliance: Major progress in establishing battery manufacturing in Europe in only one year

23-10-2018

One year on from the launch of the European Battery Alliance (EBA), the Commission Action Plan is in place, the first pilot production facilities are being built and further projects are announced to establish the EU as the lead player in the strategic area of battery innovation and manufacturing.
Read more

Innovative Medicines Initiative: European recognition of Luxembourg biobanking expertise

22-10-2018

The Integrated Biobank of Luxembourg (IBBL) is participating in two unique European research projects, LITMUS and CANCER-ID, under the umbrella of the Innovative Medicines Initiative (IMI) partnerships.
Read more

All news

Close